Abstract
■ Fluorescein angiography should be performed in any case of retinal vasculitis as soon as the media are transparent enough to allow it.
■ The affected area revealed by fluorescein angiography is usually greater than what is suspected by ophthalmoscopy.
■ We must pay special attention to the retina distal to the area affected by vasculitis: this will frequently be affected by ischemia.
■ Treatment should be started as soon as possible in ischemic cases in order to prevent neovascularization.
■ Concomitant steroidal therapy and adequate dosage are of utmost importance in order to control vasculitis.
■ The ischemic area should be treated by laser ablation under topical anesthesia in order to prevent neovascularization or to reduce it.
■ Posterior three-port vitrectomy should be performed in case of recurrent or persistent vitreous hemorrhage, vitreoretinal traction with macular distortion, or tractional retinal detachment.
■ Posterior three-port vitrectomy is useful to remove hemorrhages, perform resection of new vessels and associated traction and perform endophotocoagulation.
■ New technology such as 25-gauge vitrectomy should be considered in order to reduce surgical trauma.
■ The development of new antiangiogenic drugs (anti- VEGF) may offer a new therapeutic alternative to these cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abu El-Asrar AM, Al-Obeidan SA, Abdel G, et al. (2003). Retinal periphlebitis resembling frosted branch angiitis with nonperfused central retinal vein occlusion. Eur J Ophthalmol 13: 807–812
Abu El-Asrar AM, Herbort P, Tabbara KF (2005). Retinal vasculitis. Ocul Immunol Inflamm 13:415–433
Abu El-Asrar AM, Naddaf HO, Al-Momen AK, et al. (1995). Systemic lupus erythematosus flare-up manifesting as a cilioretinal artery occlusion. Lupus 4:158–160
Abu El-Asrar AM, AL-Kharashi SA (2002). Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales’ disease). Br J Ophthalmol 86:1248–1251
Alio J, Ruiz-Beltran R, Herrero-Herrero JI, et al. (1987). Spotted fever. Ophthalmologica 195:31–37
Atmaca L, Nagpal P (1998). Eales´ disease: medical, laser and surgical treatments. Ophthalmol Clin North Am 11:619–626
Ayliffe W (2002). Retinal vasculitis. In: Foster CS, Vitale AT. Dianosis and treatment of uveitis. Philadelphia, Saunders
Barouch FC, Miller JW (2004). Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularisation from age-related macular degeneration. Int Ophthalmol Clin 44:23–30
Bentley CR, Stanford MR, Shilling JS, et al. (1993). Macular ischaemia in posterior uveitis. Eye 7:411–414
Brockhurst RJ, Schepens CL (1968). Uveitis IV. Peripheral uveitis, the complication of retinal detachment. Arch Ophthalmol 80:747–753
Blumenkranz MS, Kaplan HJ, Clarkson JG, et al. (1988). Acute multifocal hemorrhagic retinal vasculitis. Ophthalmology 95:1663–1672
Borkowski LM, Jampol LM (1999). Frosted branch angiitis complicated by retinal neovascularization. Retina 19:454–455
Bullen CL, Liesegang TJ, McDonald TJ, et al. (1983). Ocular complications of Wegener’s granulomatosis. Ophthalmology 90:279–290
Chang TS, Aylward W, Davis JL, et al. (1995). The Retinal Vasculitis Study Group. Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis. Ophthalmology 102:1089–1097
Dvorak HF, Brown LF, Detmar M, et al. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146:1029–1039
Eales H (1880). Cases of retinal hemorrhage associated with epistaxis and constipation. Birmingham Med Rev 9:262
Edwards AO, Ritter R, Abel KJ, et al. (2005). Complement factor H polymorphism and age-related macular degeneration. Science 308:421–424
Ferrara N (2004). Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611
Ferrara N, Gerber HP, LeCouter J (2003). The biology of VEGF and its receptors. Nat Med 9:669–676
Gass JDM, Tiedeman J, Thomas MA (1986). Idiopathic recurrent branch retinal arterial occlusion. Ophthalmology 93:1148–1157
Graham E, Stanford MR, Shillings JS, et al. (1987). Neovascularization associated with posterior uveitis. Br J Ophthalmol 71:826–833
Hageman GS, Anderson DH, Johnson LV, et al. (2005). A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proceedings of the National Academy of Sciences, USA 102:7227–7232
Herbort CP, Cimino L, Abu El-Asrar AM (2005). Ocular vasculitis: a multidisciplinary approach. Curr Opin Rheumatol 17:25–33
Hsu CT, Kerrison JB, Miller NR, et al. (2001). Choroidal infarction, ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa. Retina 21:348–351
Iida T, Spaide RF, Kantor J (2002). Retinal and choroidal arterial occlusion in Wegener’s granulomatosis. Am J Ophthalmol 133:151–152
Jabs DA, Fine SL, Hochberg MC, et al. (1986). Severe retinal vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol 104:558–563
Khairallah M, Ladjimi A, Chakroun M, et al. (2004). Posterior segment manifestations of Rickettsia conorii infection. Ophthalmology 111:529–534
Kleiner RC, Kaplan HJ, Shakin JL, et al. (1988). Acute frosted retinal periphlebitis. Am J Ophthalmol 106:27–34
Koch AE, Polverini PJ, Kumkel SL, et al. (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798–1801
Kukk E, Lymboussaki A, Taira S, et al. (1996). VEGF-C receptor binding and pattern of expression with VEGRR-3 suggest a role in lymphatic vascular development. Development 122:3829–3837
Kwak N, Okamoto N, Wood JM, Campochiaro PA (2000). VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41:3158–3164
Morgan CM, Foster CS, Gragoudas ES (1986). Retinal vasculitis in polyarteritis nodosa. Retina 6:205–209
Nicholas J (2002). Sarcoidosis. Curr Opin Ophthalmol 13:393–396
Nussenblatt R, Whitcup S, Palestine A (1996). Retina vasculitis. In: Uveitis: Fundamentals and Clinical Practice. St Louis, Mosby
Okada AA (2000). Drug therapy in Behçet’s disease. Ocul Immunol Inflamm 8:85–91
Ormerod LD, Dailey JP (1999). Ocular manifestations of cat-scratch disease. Curr Opin Ophthalmol 10:209–216
Palmer HE, Stanford MR, Sanders MD, et al. (1996). Visual outcome of patients with idiopathic ischaemic and non-ischaemic retinal vasculitis. Eye 10:343–348
Parfyonova YV, Plekhanova OS, Tkachuk VA (2002). Plasminogen activators in vascular remodelling and angiogenesis. Biochem (Moscow) 67:139–156
Pepper MS (2001). Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21:1104–1117
Perez VL, Chavala SH, Ahmed M, et al. (2004). Ocular manifestations and concepts of systemic vasculitides. Surv Ophthalmol 49:399–418
Rothova A (2000). Ocular involvement in sarcoidosis. Br J Ophthalmol 84:110–116
Ruiz-Moreno JM (1997). Choroidal neovascularization in the course of Q fever. Retina 17:553–555
Sakane T, Takeno M (2000). Novel approaches to Behçet’s disease. Expert Opin Investig Drugs 9:1993–2005
Saatci OA, Koçak N, Durak I, et al. (2002). Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn’s disease. Int Ophthalmol 24:89–92
Salmon JF, Ursell PG, Frith P (2000). Neovascular glaucoma as a complication of retinal vasculitis in Crohn’s disease. Am J Ophthalmol 130:528–530
Secchi AG, Tognon MS, Piermarocchi S, et al. (1999). Idiopathic retinal vasculitis. In: BenEzra D, Ocular inflammation. London, Martin Dunitz, pp 267–274
Smith JL, Winward KE, Nicholson DF, et al. (1991). Retinal vasculitis in Lyme borreliosis. J Clin Neuroophthalmol 11:7–15
Theodossiodis P, Kokolakis S, Ladas I, et al. (1995). Retinal vascular involvement in acute toxoplasmic retinochoroiditis. Int Ophthalmol 19:19–24
Van Bruggen N (1999). VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 104:1613–1620
Vanrenterghem Y, Roels L, Lerut T, et al. (1985). Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 8436:999–1002
Verity DH, Wallace GR, Vaughan RW, et al. (2003). Behçet’s disease: from Hippocrates to the third millennium. Br J Ophthalmol 87:1175–1183
Vine AK (1992). Severe periphlebitis, peripheral retinal ischemia, and preretinal neovascularization in patients with multiple sclerosis. Am J Ophthalmol 113:28–32
Yancopoulos GD, Davis S, Gale NW, et al. (2000). Vascular-specific growth factor and blood vessel formation. Nature 407:242–248
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ruiz-Moreno, J., Montero, J. (2008). Surgical Treatment of Retinal Vasculitis with Occlusion, Neovascularization or Traction. In: Becker, M., Davis, J. (eds) Surgical Management of Inflammatory Eye Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33862-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-540-33862-8_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33861-1
Online ISBN: 978-3-540-33862-8
eBook Packages: MedicineMedicine (R0)